HC Wainwright Reiterates “Buy” Rating for Anavex Life Sciences (NASDAQ:AVXL)
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a note issued to investors on Monday,Benzinga reports. They presently have a $42.00 price target on the biotechnology company’s stock. HC Wainwright’s price target would suggest a potential upside of 452.63% from the stock’s previous close. Separately, […]
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a note issued to investors on Monday,Benzinga reports. They presently have a $42.00 price target on the biotechnology company’s stock. HC Wainwright’s price target would suggest a potential upside of 452.63% from the stock’s previous close. Separately, […]
